US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ashland

64.80

+1.582.50%

Pre-market: 64.60-0.2000-0.31%09:16 EST

Volume:746.80K

Turnover:48.00M

Market Cap:2.97B

PE:-4.28

High:64.84

Open:62.77

Low:62.29

Close:63.22

52wk High:66.40

52wk Low:45.21

Shares:45.76M

Float Shares:41.77M

Volume Ratio:0.86

T/O Rate:1.79%

Dividend:1.65

Dividend Rate:2.55%

EPS(TTM):-15.1257

EPS(LYR):-18.3696

ROE:-29.98%

ROA:2.09%

PB:1.58

PE(LYR):-3.53

Loading ...

Overview Company News Filings

HUTCHMED (00013) to Present Clinical Data at 2025 ESMO Asia Congress and ASH Annual Meeting

HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting

Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS

Eli Lilly to present data from 2 Jaypirca studies at ASH Annual Meeting

Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting

Press Release: BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update

PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting

Minovia’s mitochondrial augmentation tech to be featured at ASH meeting

Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition

Ashland Maintains Quarterly Dividend at $0.415 a Share, Payable Dec. 15 to Shareholders of Record on Dec. 1

MT Newswires Live

Ashland Inc. announces $0.415 quarterly dividend

A Fresh Look at Terns Pharmaceuticals (TERN) Valuation Following New CARDINAL Trial Results and ASH Presentation

Simply Wall St.

Ashland (ASH) Issues 2026 Growth Outlook After Mixed FY25 Results – Is Margin Improvement Sustainable?

Simply Wall St.

Press Release: TuHURA Biosciences, Inc. Reports Third Quarter 2025 Financial Results and Provides a Corporate Update

Press Release: Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual Meeting in December

Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates

Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple Myeloma, Lymphoma and Paroxysmal Nocturnal Hemoglobinuria Programs

Ascentage Pharma (SEHK:6855): Evaluating Valuation After ASH Meeting Spotlights Pipeline Progress

Simply Wall St.

Press Release: SELLAS Life Sciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update

Ashland : Deutsche Bank Raises Target Price to $58 From $55

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/ASH/news?page=7"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ASH","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASH\",,,,,undefined,":{"symbol":"ASH","market":"US","secType":"STK","nameCN":"Ashland","latestPrice":64.8,"timestamp":1771621200000,"preClose":63.22,"halted":0,"volume":746801,"hourTrading":{"tag":"盘前","latestPrice":64.6,"preClose":64.8,"latestTime":"09:16 EST","volume":149,"amount":9633.53987,"timestamp":1771856189469,"change":-0.2,"changeRate":-0.003086,"amplitude":0.01821},"delay":0,"changeRate":0.024992091110408073,"floatShares":41773472,"shares":45762099,"eps":-15.125683,"marketStatus":"Pre-Mkt","change":1.58,"latestTime":"02-23 09:16:35 EST","open":62.77,"high":64.84,"low":62.29,"amount":48002201.60294,"amplitude":0.040335,"askPrice":80.28,"askSize":100,"bidPrice":64.5,"bidSize":3,"shortable":3,"etf":0,"ttmEps":-15.125683,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1771857000000},"marketStatusCode":1,"adr":0,"adrRate":0,"exchange":"NYSE","adjPreClose":64.8,"dividendRate":0.025463,"preHourTrading":{"tag":"盘前","latestPrice":64.6,"preClose":64.8,"latestTime":"09:16 EST","volume":149,"amount":9633.53987,"timestamp":1771856189469,"change":-0.2,"changeRate":-0.003086,"amplitude":0.01821},"postHourTrading":{"tag":"盘后","latestPrice":64.8,"preClose":64.8,"latestTime":"17:50 EST","volume":8076,"amount":523322.25,"timestamp":1771627831604,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.864430361311767,"impliedVol":0.3513,"impliedVolPercentile":0.224},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ASH\",,,,,undefined,":{"symbol":"ASH","floatShares":41773472,"roa":"2.09%","roe":"-29.98%","lyrEps":-18.369565,"volumeRatio":0.864430361311767,"shares":45762099,"dividePrice":1.65,"high":64.84,"amplitude":0.040335,"preClose":63.22,"low":62.29,"week52Low":45.21,"pbRate":"1.58","psRate":"1.64","week52High":66.4,"institutionHeld":0.8513,"latestPrice":64.8,"committee":-0.941748,"eps":-15.125683,"divideRate":0.025463,"volume":746801,"delay":0,"ttmEps":-15.125683,"open":62.77,"prevYearClose":58.67,"prevWeekClose":64.8,"prevMonthClose":61.16,"prevQuarterClose":58.67,"fiveDayClose":61.03,"twentyDayClose":63.09,"sixtyDayClose":50.37,"dividendPayoutRate":0.4581065874857458,"dividendFrequency":"Q","dividendGrowthYears":7,"dividendGrowthRate":0.037974683544303826,"fiveYearAvgDividendRate":0.01932116730388857},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ASH\",params:#limit:5,,,undefined,":[{"date":"2026-02-27","symbol":"ASH","amount":0.415,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-01","defaultRemindTime":1772202600000,"name":"Ashland","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-15","payableDate":"2026-03-01","currency":"USD","dateTimestamp":1772168400000,"payDate":"2026-03-15"},{"market":"US","date":"2026-02-02","symbol":"ASH","fiscalQuarterEnding":"2025/12","expectedEps":0.23,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1770008400000,"reportTimeType":"post","actualEps":0.26},{"date":"2025-12-01","symbol":"ASH","amount":0.415,"announcedDate":"2025-11-19","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-01","defaultRemindTime":1764599400000,"name":"Ashland","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-15","payableDate":"2025-12-01","currency":"USD","dateTimestamp":1764565200000,"payDate":"2025-12-15"},{"market":"US","date":"2025-11-04","symbol":"ASH","fiscalQuarterEnding":"2025/09","expectedEps":1.17,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"post","actualEps":1.08},{"date":"2025-08-29","symbol":"ASH","amount":0.415,"announcedDate":"2025-08-08","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-09-01","defaultRemindTime":1756474200000,"name":"Ashland","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-09-15","payableDate":"2025-09-01","currency":"USD","dateTimestamp":1756440000000,"payDate":"2025-09-15"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ASH\",market:\"US\",,,undefined,":[{"executeDate":"2016-06-01","recordDate":"2016-06-03","paymentDate":"2016-06-15","value":0.39,"currency":"USD"},{"executeDate":"2016-08-17","recordDate":"2016-08-19","paymentDate":"2016-09-15","value":0.39,"currency":"USD"},{"executeDate":"2016-11-29","recordDate":"2016-12-01","paymentDate":"2016-12-15","value":0.39,"currency":"USD"},{"executeDate":"2017-02-27","recordDate":"2017-03-01","paymentDate":"2017-03-15","value":0.39,"currency":"USD"},{"executeDate":"2017-05-30","recordDate":"2017-06-01","paymentDate":"2017-06-15","value":0.225,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ASH\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.2308,"buy":0.4615,"hold":0.3077,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.4615,"analysts":13,"updateTime":1765861200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ASH\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ASH","date":"2026-02-20","current":-4.284104,"percent":0.144159,"low":-152.607239,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"high":41.666396,"avg":6.843327,"sd":34.757783,"marketCap":2893079898},"quantilePoints":[{"date":"2021-02-26","current":-10.544092,"twenty":-41.685517,"median":16.708151,"eighty":45.060758,"marketCap":5103340678},{"date":"2021-03-05","current":-10.893807,"twenty":-41.766144,"median":16.655852,"eighty":45.067329,"marketCap":5272602691},{"date":"2021-03-12","current":-11.366361,"twenty":-41.766144,"median":16.626772,"eighty":45.067329,"marketCap":5501318743},{"date":"2021-03-19","current":-11.074305,"twenty":-41.766144,"median":16.605449,"eighty":45.067329,"marketCap":5359963729},{"date":"2021-03-26","current":-11.298674,"twenty":-41.685517,"median":16.565507,"eighty":45.060758,"marketCap":5468558354},{"date":"2021-04-01","current":-11.32625,"twenty":-41.685517,"median":16.544159,"eighty":45.032615,"marketCap":5481905179},{"date":"2021-04-09","current":-11.130711,"twenty":-41.766144,"median":16.513421,"eighty":45.025182,"marketCap":5387264054},{"date":"2021-04-16","current":-11.373882,"twenty":-41.766144,"median":16.49824,"eighty":44.88663,"marketCap":5504958787},{"date":"2021-04-23","current":-11.615799,"twenty":-41.766144,"median":16.458163,"eighty":44.798223,"marketCap":5622046845},{"date":"2021-04-30","current":37.652621,"twenty":-41.766144,"median":16.458163,"eighty":44.763306,"marketCap":5233714269},{"date":"2021-05-07","current":38.556703,"twenty":-41.766144,"median":16.48927,"eighty":44.763306,"marketCap":5359381692},{"date":"2021-05-14","current":38.897371,"twenty":-41.766144,"median":16.508117,"eighty":44.763306,"marketCap":5406734634},{"date":"2021-05-21","current":38.897371,"twenty":-41.766144,"median":16.532217,"eighty":44.763306,"marketCap":5406734634},{"date":"2021-05-28","current":41.421813,"twenty":-41.766144,"median":16.539302,"eighty":44.763306,"marketCap":5757632076},{"date":"2021-06-04","current":41.177231,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5723635092},{"date":"2021-06-11","current":40.923913,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5688423930},{"date":"2021-06-18","current":38.067538,"twenty":-41.766144,"median":16.551203,"eighty":44.763306,"marketCap":5291387724},{"date":"2021-06-25","current":38.72267,"twenty":-41.766144,"median":16.559996,"eighty":44.763306,"marketCap":5382451074},{"date":"2021-07-02","current":38.32959,"twenty":-41.766144,"median":16.589527,"eighty":44.763306,"marketCap":5327813064},{"date":"2021-07-09","current":38.399471,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5337526488},{"date":"2021-07-16","current":37.713766,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5242213515},{"date":"2021-07-23","current":38.233504,"twenty":-41.766144,"median":16.609898,"eighty":44.763306,"marketCap":5314457106},{"date":"2021-07-30","current":28.544675,"twenty":-41.766144,"median":16.63409,"eighty":44.763306,"marketCap":5166586254},{"date":"2021-08-06","current":28.329928,"twenty":-41.766144,"median":16.642592,"eighty":44.763306,"marketCap":5127716909},{"date":"2021-08-13","current":29.118455,"twenty":-41.766144,"median":16.707431,"eighty":44.763306,"marketCap":5270440286},{"date":"2021-08-20","current":28.051427,"twenty":-41.766144,"median":16.798988,"eighty":44.763306,"marketCap":5077308227},{"date":"2021-08-27","current":29.259383,"twenty":-41.766144,"median":16.876011,"eighty":44.763306,"marketCap":5295948294},{"date":"2021-09-03","current":31.51759,"twenty":-41.685517,"median":16.928602,"eighty":44.762757,"marketCap":5704683753},{"date":"2021-09-10","current":31.051184,"twenty":-41.685517,"median":16.94157,"eighty":44.762757,"marketCap":5620264394},{"date":"2021-09-17","current":30.272724,"twenty":-41.685517,"median":16.987677,"eighty":44.762757,"marketCap":5479363017},{"date":"2021-09-24","current":31.121649,"twenty":-41.685517,"median":16.987677,"eighty":44.762757,"marketCap":5633018398},{"date":"2021-10-01","current":30.59149,"twenty":-41.685517,"median":19.684212,"eighty":44.762757,"marketCap":5537059701},{"date":"2021-10-08","current":31.071317,"twenty":-41.685517,"median":19.787677,"eighty":44.762757,"marketCap":5623908395},{"date":"2021-10-15","current":32.124923,"twenty":-41.685517,"median":19.83941,"eighty":44.762757,"marketCap":5814611120},{"date":"2021-10-22","current":32.826209,"twenty":-41.685517,"median":19.917009,"eighty":44.762757,"marketCap":5941543826},{"date":"2021-10-29","current":32.21552,"twenty":-41.604889,"median":19.999764,"eighty":44.762207,"marketCap":5831009125},{"date":"2021-11-05","current":32.916806,"twenty":-41.604889,"median":20.15896,"eighty":44.762207,"marketCap":5957941831},{"date":"2021-11-12","current":29.342491,"twenty":-41.604889,"median":20.28364,"eighty":44.762207,"marketCap":6455347984},{"date":"2021-11-19","current":30.162391,"twenty":-41.604889,"median":20.500749,"eighty":44.762207,"marketCap":6635726039},{"date":"2021-11-26","current":26.923508,"twenty":-41.604889,"median":20.528215,"eighty":44.762207,"marketCap":5923171764},{"date":"2021-12-03","current":26.411959,"twenty":-41.604889,"median":20.552965,"eighty":44.762207,"marketCap":5810630932},{"date":"2021-12-10","current":27.165993,"twenty":-41.604889,"median":20.676932,"eighty":44.762207,"marketCap":5976518382},{"date":"2021-12-17","current":26.837476,"twenty":-41.604889,"median":20.708356,"eighty":44.762207,"marketCap":5904244736},{"date":"2021-12-23","current":26.982334,"twenty":-41.604889,"median":20.728755,"eighty":44.762207,"marketCap":5936113430},{"date":"2021-12-31","current":27.848893,"twenty":-41.604889,"median":20.764302,"eighty":44.762207,"marketCap":6126756513},{"date":"2022-01-07","current":26.876277,"twenty":-41.524262,"median":20.796751,"eighty":44.761658,"marketCap":5912780993},{"date":"2022-01-14","current":27.341891,"twenty":-41.524262,"median":20.868148,"eighty":44.761658,"marketCap":6015216083},{"date":"2022-01-21","current":25.013821,"twenty":-41.524262,"median":20.917445,"eighty":44.761658,"marketCap":5503040636},{"date":"2022-01-28","current":24.677544,"twenty":-41.524262,"median":20.980342,"eighty":44.761658,"marketCap":5429059738},{"date":"2022-02-04","current":25.572734,"twenty":-41.443634,"median":21.023702,"eighty":44.761108,"marketCap":5421419569},{"date":"2022-02-11","current":25.553938,"twenty":-41.443634,"median":21.065338,"eighty":44.761108,"marketCap":5417434905},{"date":"2022-02-18","current":25.494866,"twenty":-41.443634,"median":21.115412,"eighty":44.761108,"marketCap":5404911676},{"date":"2022-02-25","current":25.29617,"twenty":-41.443634,"median":21.157984,"eighty":44.761108,"marketCap":5362788089},{"date":"2022-03-04","current":23.572347,"twenty":-41.443634,"median":21.240692,"eighty":44.761108,"marketCap":4997337504},{"date":"2022-03-11","current":23.66901,"twenty":-41.443634,"median":21.332705,"eighty":44.761108,"marketCap":5017830061},{"date":"2022-03-18","current":25.352557,"twenty":-41.443634,"median":21.402701,"eighty":44.761108,"marketCap":5374742080},{"date":"2022-03-25","current":26.448071,"twenty":-41.443634,"median":21.507199,"eighty":44.761108,"marketCap":5606991049},{"date":"2022-04-01","current":26.544734,"twenty":-41.443634,"median":21.611248,"eighty":44.761108,"marketCap":5627483605},{"date":"2022-04-08","current":26.703154,"twenty":-41.443634,"median":21.681627,"eighty":44.761108,"marketCap":5661068628},{"date":"2022-04-14","current":28.520955,"twenty":-41.443634,"median":21.86021,"eighty":44.761108,"marketCap":6046442530},{"date":"2022-04-22","current":27.734226,"twenty":-41.443634,"median":22.114023,"eighty":44.761108,"marketCap":5879655893},{"date":"2022-04-29","current":5.98168,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5724467780},{"date":"2022-05-06","current":5.79477,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5545595204},{"date":"2022-05-13","current":5.627805,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5385809640},{"date":"2022-05-20","current":5.695617,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5450705483},{"date":"2022-05-27","current":6.155649,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5890955748},{"date":"2022-06-03","current":6.053281,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5792989652},{"date":"2022-06-10","current":5.809521,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5559711268},{"date":"2022-06-17","current":5.398352,"twenty":-41.443634,"median":22.157672,"eighty":44.761108,"marketCap":5166223136},{"date":"2022-06-24","current":5.835537,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5584608729},{"date":"2022-07-01","current":5.86325,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5611129938},{"date":"2022-07-08","current":5.737128,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5490431377},{"date":"2022-07-15","current":5.58499,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5344835356},{"date":"2022-07-22","current":5.922634,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5667961098},{"date":"2022-07-29","current":5.951187,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5439385116},{"date":"2022-08-05","current":6.14725,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5618586516},{"date":"2022-08-12","current":6.304219,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5762055916},{"date":"2022-08-19","current":6.275787,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5736069006},{"date":"2022-08-26","current":6.098679,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5574192212},{"date":"2022-09-02","current":5.884253,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5378207598},{"date":"2022-09-09","current":6.054846,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5534129059},{"date":"2022-09-16","current":5.848121,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5345182567},{"date":"2022-09-23","current":5.752755,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5258018139},{"date":"2022-09-30","current":5.625403,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5141618438},{"date":"2022-10-07","current":5.617703,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5134580316},{"date":"2022-10-14","current":5.641396,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5156236075},{"date":"2022-10-21","current":5.922755,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5413398206},{"date":"2022-10-28","current":6.27401,"twenty":-41.524262,"median":22.199705,"eighty":44.761658,"marketCap":5734444824},{"date":"2022-11-04","current":5.909724,"twenty":-41.524262,"median":21.695313,"eighty":44.761658,"marketCap":5401487538},{"date":"2022-11-11","current":6.292902,"twenty":-41.524262,"median":21.556282,"eighty":44.761658,"marketCap":5833519919},{"date":"2022-11-18","current":6.534105,"twenty":-41.524262,"median":9.134384,"eighty":44.761658,"marketCap":6057115624},{"date":"2022-11-25","current":6.524573,"twenty":-41.524262,"median":9.120072,"eighty":44.761658,"marketCap":6048278877},{"date":"2022-12-02","current":6.634386,"twenty":-41.524262,"median":9.077138,"eighty":44.761658,"marketCap":6150076230},{"date":"2022-12-09","current":6.425327,"twenty":-41.524262,"median":9.031818,"eighty":44.761658,"marketCap":5956278049},{"date":"2022-12-16","current":6.216944,"twenty":-41.524262,"median":8.981727,"eighty":44.761658,"marketCap":5763107329},{"date":"2022-12-23","current":6.332842,"twenty":-41.524262,"median":8.929251,"eighty":44.761658,"marketCap":5870544977},{"date":"2022-12-30","current":6.29421,"twenty":-41.524262,"median":8.870812,"eighty":44.761658,"marketCap":5834732428},{"date":"2023-01-06","current":6.238017,"twenty":-41.524262,"median":8.723665,"eighty":44.669031,"marketCap":5782641447},{"date":"2023-01-13","current":6.570492,"twenty":-41.524262,"median":8.558011,"eighty":44.528495,"marketCap":6090846415},{"date":"2023-01-20","current":6.436448,"twenty":-41.524262,"median":8.531792,"eighty":44.433823,"marketCap":5966587722},{"date":"2023-01-27","current":6.301234,"twenty":-41.524262,"median":8.3296,"eighty":44.14834,"marketCap":5841243800},{"date":"2023-02-03","current":6.219087,"twenty":-40.702575,"median":8.3296,"eighty":44.14834,"marketCap":5715340826},{"date":"2023-02-10","current":6.142315,"twenty":-11.558641,"median":8.3296,"eighty":44.14834,"marketCap":5644787763},{"date":"2023-02-17","current":6.10452,"twenty":-11.342294,"median":8.3296,"eighty":44.14834,"marketCap":5610053948},{"date":"2023-02-24","current":6.038378,"twenty":-11.297421,"median":8.3296,"eighty":44.14834,"marketCap":5549269770},{"date":"2023-03-03","current":6.122827,"twenty":-11.1811,"median":8.3296,"eighty":44.14834,"marketCap":5626878140},{"date":"2023-03-10","current":5.75019,"twenty":-11.13773,"median":8.3296,"eighty":44.14834,"marketCap":5284424426},{"date":"2023-03-17","current":5.610229,"twenty":-11.066032,"median":8.3296,"eighty":44.14834,"marketCap":5155800765},{"date":"2023-03-24","current":5.809835,"twenty":-10.976285,"median":8.3296,"eighty":44.14834,"marketCap":5339238729},{"date":"2023-03-31","current":6.065544,"twenty":-10.897567,"median":8.324965,"eighty":44.139273,"marketCap":5574234700},{"date":"2023-04-06","current":5.988772,"twenty":-10.820856,"median":8.324965,"eighty":44.139273,"marketCap":5503681637},{"date":"2023-04-14","current":6.134638,"twenty":-10.775982,"median":8.3296,"eighty":44.14834,"marketCap":5637732457},{"date":"2023-04-21","current":6.151764,"twenty":-10.730374,"median":8.3296,"eighty":44.14834,"marketCap":5653471217},{"date":"2023-04-27","current":5.856489,"twenty":-10.606264,"median":8.340928,"eighty":44.166474,"marketCap":5382113282},{"date":"2023-05-05","current":20.861975,"twenty":-10.43882,"median":8.452838,"eighty":44.175541,"marketCap":4693944269},{"date":"2023-05-12","current":20.287633,"twenty":-10.336151,"median":8.558011,"eighty":44.182524,"marketCap":4564717446},{"date":"2023-05-19","current":21.14158,"twenty":-10.102877,"median":8.693871,"eighty":44.189507,"marketCap":4756855455},{"date":"2023-05-26","current":20.227136,"twenty":-9.78508,"median":8.870812,"eighty":44.196491,"marketCap":4551105489},{"date":"2023-06-02","current":19.892072,"twenty":-9.536436,"median":8.929251,"eighty":44.196491,"marketCap":4475716188},{"date":"2023-06-09","current":20.206194,"twenty":-9.454384,"median":8.98113,"eighty":44.203474,"marketCap":4546393658},{"date":"2023-06-16","current":20.073565,"twenty":-9.376314,"median":9.018699,"eighty":44.210457,"marketCap":4516552059},{"date":"2023-06-23","current":19.475569,"twenty":-9.301666,"median":9.056863,"eighty":44.224123,"marketCap":4382003099},{"date":"2023-06-29","current":19.508145,"twenty":-9.246426,"median":9.092642,"eighty":44.237789,"marketCap":4389332615},{"date":"2023-07-05","current":20.315555,"twenty":-9.193781,"median":9.114705,"eighty":44.251456,"marketCap":4570999888},{"date":"2023-07-14","current":20.455165,"twenty":-9.060547,"median":9.163604,"eighty":44.278788,"marketCap":4602412096},{"date":"2023-07-20","current":21.216038,"twenty":-8.93818,"median":19.183552,"eighty":44.278788,"marketCap":4773608633},{"date":"2023-07-28","current":19.591649,"twenty":4.319692,"median":19.750135,"eighty":44.283744,"marketCap":4682404042},{"date":"2023-08-04","current":19.289348,"twenty":4.38581,"median":19.591649,"eighty":44.129229,"marketCap":4610154209},{"date":"2023-08-11","current":19.13927,"twenty":4.38581,"median":19.482306,"eighty":43.956729,"marketCap":4574285498},{"date":"2023-08-18","current":18.466062,"twenty":4.38581,"median":19.154278,"eighty":43.542383,"marketCap":4413388708},{"date":"2023-08-25","current":18.088722,"twenty":4.38581,"median":18.641868,"eighty":43.319191,"marketCap":4323204519},{"date":"2023-08-31","current":18.781226,"twenty":4.38581,"median":18.466062,"eighty":42.973946,"marketCap":4488713001},{"date":"2023-09-08","current":17.87218,"twenty":4.380867,"median":18.294543,"eighty":42.623722,"marketCap":4271451093},{"date":"2023-09-13","current":17.293307,"twenty":4.378395,"median":18.166977,"eighty":42.388429,"marketCap":4133100350},{"date":"2023-09-22","current":18.005107,"twenty":4.319692,"median":17.86146,"eighty":42.077012,"marketCap":4303220523},{"date":"2023-09-29","current":17.479833,"twenty":4.263461,"median":17.50556,"eighty":41.816324,"marketCap":4177680034},{"date":"2023-10-06","current":17.087485,"twenty":4.263461,"median":17.293307,"eighty":41.73771,"marketCap":4083908975},{"date":"2023-10-13","current":16.418565,"twenty":4.263461,"median":16.945983,"eighty":41.577207,"marketCap":3924037005},{"date":"2023-10-20","current":16.294214,"twenty":4.207231,"median":16.495748,"eighty":41.332109,"marketCap":3894317216},{"date":"2023-10-27","current":16.257767,"twenty":-1.056217,"median":16.28671,"eighty":41.192954,"marketCap":3885606243},{"date":"2023-11-03","current":16.332806,"twenty":-6.207204,"median":16.153784,"eighty":40.948113,"marketCap":3903540598},{"date":"2023-11-10","current":15.616718,"twenty":-6.207204,"median":15.881499,"eighty":40.817223,"marketCap":3732395605},{"date":"2023-11-17","current":16.390693,"twenty":-6.207204,"median":15.574911,"eighty":40.340898,"marketCap":3917375673},{"date":"2023-11-24","current":22.827913,"twenty":-6.207204,"median":15.574911,"eighty":39.96161,"marketCap":4063368468},{"date":"2023-12-01","current":23.015098,"twenty":-8.782697,"median":15.533103,"eighty":39.312288,"marketCap":4096687371},{"date":"2023-12-07","current":23.654406,"twenty":-6.207204,"median":15.574911,"eighty":38.926597,"marketCap":4210484243},{"date":"2023-12-15","current":24.893249,"twenty":-8.782697,"median":15.533103,"eighty":38.72267,"marketCap":4430998377},{"date":"2023-12-22","current":24.325418,"twenty":-8.782697,"median":15.533103,"eighty":38.648421,"marketCap":4329924480},{"date":"2023-12-29","current":24.225549,"twenty":-8.789917,"median":12.47951,"eighty":38.641433,"marketCap":4312147664},{"date":"2024-01-05","current":22.661874,"twenty":-8.797137,"median":9.425916,"eighty":38.597758,"marketCap":4033813516},{"date":"2024-01-12","current":23.423737,"twenty":-8.797137,"median":9.425916,"eighty":38.470225,"marketCap":4169425227},{"date":"2024-01-19","current":22.447867,"twenty":-8.804357,"median":9.30281,"eighty":38.332211,"marketCap":3995720339},{"date":"2024-01-26","current":22.718942,"twenty":-8.797137,"median":9.425916,"eighty":38.217781,"marketCap":4043971696},{"date":"2024-02-02","current":28.85349,"twenty":-8.797137,"median":9.425916,"eighty":38.049194,"marketCap":4731972377},{"date":"2024-02-09","current":27.918791,"twenty":-8.797137,"median":9.425916,"eighty":37.903318,"marketCap":4578681720},{"date":"2024-02-16","current":28.325049,"twenty":-8.797137,"median":9.425916,"eighty":37.631656,"marketCap":4645308051},{"date":"2024-02-23","current":28.413632,"twenty":-8.797137,"median":9.425916,"eighty":37.11978,"marketCap":4659835597},{"date":"2024-03-01","current":28.603015,"twenty":-8.789917,"median":12.47951,"eighty":32.879225,"marketCap":4690894489},{"date":"2024-03-08","current":29.339167,"twenty":-8.789917,"median":12.47951,"eighty":32.536971,"marketCap":4811623405},{"date":"2024-03-15","current":29.363604,"twenty":-8.789917,"median":12.47951,"eighty":32.258469,"marketCap":4815631004},{"date":"2024-03-22","current":29.357495,"twenty":-8.789917,"median":12.47951,"eighty":31.941046,"marketCap":4814629104},{"date":"2024-03-28","current":29.81568,"twenty":-8.789917,"median":12.47951,"eighty":31.40619,"marketCap":4889771583},{"date":"2024-04-05","current":29.122292,"twenty":-8.797137,"median":9.425916,"eighty":31.117622,"marketCap":4776055965},{"date":"2024-04-12","current":29.372767,"twenty":-8.797137,"median":9.425916,"eighty":31.051184,"marketCap":4817133853},{"date":"2024-04-19","current":29.168111,"twenty":-8.797137,"median":9.425916,"eighty":30.606254,"marketCap":4783570213},{"date":"2024-04-26","current":29.079528,"twenty":-8.789917,"median":12.47951,"eighty":30.256618,"marketCap":4769042667},{"date":"2024-05-03","current":24.879315,"twenty":-8.789917,"median":12.47951,"eighty":29.945905,"marketCap":4801707860},{"date":"2024-05-10","current":25.416952,"twenty":-8.789917,"median":12.47951,"eighty":29.757033,"marketCap":4905471669},{"date":"2024-05-17","current":25.614345,"twenty":-8.789917,"median":12.47951,"eighty":29.613467,"marketCap":4943568527},{"date":"2024-05-24","current":25.463703,"twenty":-8.789917,"median":12.47951,"eighty":29.5169,"marketCap":4914494609},{"date":"2024-05-31","current":25.87667,"twenty":-8.789917,"median":12.47951,"eighty":29.365437,"marketCap":4994197245},{"date":"2024-06-07","current":26.035104,"twenty":-8.789917,"median":12.47951,"eighty":29.342276,"marketCap":5024774986},{"date":"2024-06-14","current":25.292282,"twenty":-8.797137,"median":9.425916,"eighty":29.274986,"marketCap":4881410496},{"date":"2024-06-21","current":25.066319,"twenty":-8.804357,"median":9.30281,"eighty":29.230424,"marketCap":4837799620},{"date":"2024-06-28","current":24.487127,"twenty":-8.826676,"median":9.172548,"eighty":29.168722,"marketCap":4726015420},{"date":"2024-07-05","current":24.193634,"twenty":-8.826676,"median":9.172548,"eighty":29.132067,"marketCap":4669371408},{"date":"2024-07-12","current":24.601407,"twenty":-8.826676,"median":9.172548,"eighty":29.097856,"marketCap":4748071495},{"date":"2024-07-15","current":24.596212,"twenty":-8.826676,"median":9.172548,"eighty":29.090525,"marketCap":4747068946},{"date":"2024-08-02","current":24.957234,"twenty":-8.929025,"median":9.114705,"eighty":28.735731,"marketCap":4816746093},{"date":"2024-08-09","current":27.237695,"twenty":-8.929025,"median":9.114705,"eighty":28.677936,"marketCap":4058416549},{"date":"2024-08-16","current":27.91282,"twenty":-8.929025,"median":9.114705,"eighty":28.593851,"marketCap":4159010197},{"date":"2024-08-23","current":28.407693,"twenty":-8.929025,"median":9.114705,"eighty":28.535286,"marketCap":4232746318},{"date":"2024-08-30","current":29.413827,"twenty":-8.929025,"median":9.114705,"eighty":28.535286,"marketCap":4382660153},{"date":"2024-09-06","current":28.273324,"twenty":-8.929025,"median":9.114705,"eighty":28.515633,"marketCap":4212725252},{"date":"2024-09-13","current":27.91282,"twenty":-8.929025,"median":9.114705,"eighty":28.437936,"marketCap":4159010197},{"date":"2024-09-20","current":28.840298,"twenty":-8.929025,"median":9.114705,"eighty":28.414125,"marketCap":4297204384},{"date":"2024-09-27","current":28.584668,"twenty":-8.929025,"median":9.114705,"eighty":28.410315,"marketCap":4259115526},{"date":"2024-10-04","current":27.693241,"twenty":-8.929025,"median":9.114705,"eighty":28.328952,"marketCap":4126292846},{"date":"2024-10-11","current":27.781728,"twenty":-8.929025,"median":9.114705,"eighty":28.174035,"marketCap":4139477450},{"date":"2024-10-18","current":28.768197,"twenty":-8.929025,"median":9.114705,"eighty":28.155826,"marketCap":4286461373},{"date":"2024-10-25","current":27.847274,"twenty":-8.929025,"median":9.114705,"eighty":28.143107,"marketCap":4149243823},{"date":"2024-10-31","current":28.55845,"twenty":-8.929025,"median":9.114705,"eighty":28.102675,"marketCap":4255208977},{"date":"2024-11-08","current":23.317939,"twenty":-8.93818,"median":9.109339,"eighty":27.987673,"marketCap":3940731747},{"date":"2024-11-15","current":22.552233,"twenty":-8.93818,"median":9.109339,"eighty":27.96198,"marketCap":3811327297},{"date":"2024-11-22","current":21.642415,"twenty":-8.93818,"median":9.127228,"eighty":27.96083,"marketCap":3657568070},{"date":"2024-11-29","current":21.759491,"twenty":-8.93818,"median":9.172548,"eighty":27.96083,"marketCap":3677353987},{"date":"2024-12-06","current":21.310698,"twenty":-8.93818,"median":16.14628,"eighty":27.96083,"marketCap":3601507972},{"date":"2024-12-13","current":20.66399,"twenty":-8.93818,"median":16.326374,"eighty":27.96083,"marketCap":3492214336},{"date":"2024-12-20","current":20.056308,"twenty":-8.93818,"median":16.418565,"eighty":27.96083,"marketCap":3389516005},{"date":"2024-12-27","current":20.109271,"twenty":-8.93818,"median":16.564355,"eighty":27.96083,"marketCap":3398466777},{"date":"2025-01-03","current":19.440263,"twenty":-8.93818,"median":16.920255,"eighty":27.96083,"marketCap":3285404395},{"date":"2025-01-10","current":19.6399,"twenty":-8.938327,"median":17.089629,"eighty":27.96106,"marketCap":3319143109},{"date":"2025-01-17","current":19.75157,"twenty":-8.938327,"median":17.49484,"eighty":27.96106,"marketCap":3338015281},{"date":"2025-01-24","current":20.086579,"twenty":-8.938327,"median":17.759622,"eighty":27.96106,"marketCap":3394631794},{"date":"2025-01-31","current":-136.701619,"twenty":-9.032373,"median":17.86146,"eighty":27.96106,"marketCap":3007435623},{"date":"2025-02-07","current":-139.725612,"twenty":-9.144874,"median":17.86146,"eighty":27.96106,"marketCap":3073963459},{"date":"2025-02-14","current":-139.361017,"twenty":-9.245709,"median":17.86146,"eighty":27.96106,"marketCap":3065942372},{"date":"2025-02-21","current":-140.326121,"twenty":-9.301666,"median":17.86146,"eighty":27.96106,"marketCap":3087174660},{"date":"2025-02-28","current":-131.897546,"twenty":-9.377985,"median":17.86146,"eighty":27.96106,"marketCap":2901746013},{"date":"2025-03-07","current":-127.90845,"twenty":-9.455107,"median":17.87218,"eighty":27.96129,"marketCap":2813985889},{"date":"2025-03-14","current":-119.994597,"twenty":-9.579026,"median":17.87218,"eighty":27.96129,"marketCap":2639881128},{"date":"2025-03-21","current":-119.823023,"twenty":-9.954842,"median":17.87218,"eighty":27.96129,"marketCap":2636106499},{"date":"2025-03-28","current":-128.144364,"twenty":-10.210799,"median":17.87218,"eighty":27.96129,"marketCap":2819176004},{"date":"2025-04-04","current":-113.839378,"twenty":-10.377935,"median":17.87218,"eighty":27.96129,"marketCap":2504466314},{"date":"2025-04-11","current":-104.209785,"twenty":-10.499986,"median":17.86146,"eighty":27.96106,"marketCap":2292615264},{"date":"2025-04-17","current":-106.268673,"twenty":-10.617545,"median":17.86146,"eighty":27.96106,"marketCap":2337910812},{"date":"2025-04-25","current":-114.482781,"twenty":-10.734618,"median":17.87218,"eighty":27.96129,"marketCap":2518621173},{"date":"2025-05-02","current":-19.826576,"twenty":-10.796539,"median":17.87218,"eighty":27.96129,"marketCap":2240403051},{"date":"2025-05-09","current":-20.214777,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2284269804},{"date":"2025-05-16","current":-20.890086,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2360579678},{"date":"2025-05-23","current":-20.234996,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2286554531},{"date":"2025-05-30","current":-20.590847,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2326765722},{"date":"2025-06-06","current":-20.040895,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2264621154},{"date":"2025-06-13","current":-20.894129,"twenty":-10.804561,"median":17.87218,"eighty":27.96129,"marketCap":2361036623},{"date":"2025-06-20","current":-19.676956,"twenty":-10.798043,"median":17.87218,"eighty":27.96152,"marketCap":2223496073},{"date":"2025-06-27","current":-20.627241,"twenty":-10.798043,"median":17.87218,"eighty":27.96152,"marketCap":2330878230},{"date":"2025-07-03","current":-21.706926,"twenty":-10.798043,"median":17.87218,"eighty":27.96152,"marketCap":2452882638},{"date":"2025-07-11","current":-22.026383,"twenty":-10.798043,"median":17.87218,"eighty":27.96152,"marketCap":2488981321},{"date":"2025-07-18","current":-21.18528,"twenty":-10.798043,"median":17.87218,"eighty":27.96152,"marketCap":2393936688},{"date":"2025-07-25","current":-20.505928,"twenty":-10.798043,"median":17.87218,"eighty":27.96152,"marketCap":2317169869},{"date":"2025-08-01","current":-2.737049,"twenty":-10.76094,"median":17.87218,"eighty":27.96152,"marketCap":2356599194},{"date":"2025-08-08","current":-2.80022,"twenty":-10.723337,"median":17.87218,"eighty":27.96152,"marketCap":2410989284},{"date":"2025-08-15","current":-2.870292,"twenty":-10.566654,"median":17.87218,"eighty":27.96152,"marketCap":2471321149},{"date":"2025-08-22","current":-2.860736,"twenty":-10.421629,"median":17.87218,"eighty":27.96152,"marketCap":2463094076},{"date":"2025-08-29","current":-3.004596,"twenty":-10.277414,"median":17.87218,"eighty":27.96152,"marketCap":2586957222},{"date":"2025-09-05","current":-2.879316,"twenty":-10.005461,"median":17.87218,"eighty":27.96175,"marketCap":2479091161},{"date":"2025-09-12","current":-2.903204,"twenty":-9.719819,"median":17.87218,"eighty":27.96152,"marketCap":2499658843},{"date":"2025-09-19","current":-2.749789,"twenty":-9.45821,"median":17.87218,"eighty":27.96152,"marketCap":2367568624},{"date":"2025-09-26","current":-2.542228,"twenty":-9.436498,"median":17.87218,"eighty":27.96152,"marketCap":2188858328},{"date":"2025-10-03","current":-2.576733,"twenty":-9.32689,"median":17.87218,"eighty":27.96152,"marketCap":2218567201},{"date":"2025-10-10","current":-2.57461,"twenty":-9.261764,"median":17.87218,"eighty":27.96152,"marketCap":2216738963},{"date":"2025-10-17","current":-2.597967,"twenty":-9.173249,"median":17.87218,"eighty":27.96152,"marketCap":2236849584},{"date":"2025-10-24","current":-2.647336,"twenty":-9.074857,"median":17.87218,"eighty":27.96152,"marketCap":2279356125},{"date":"2025-10-31","current":-2.583634,"twenty":-8.91987,"median":17.87218,"eighty":27.96152,"marketCap":2224508975},{"date":"2025-11-07","current":-2.720181,"twenty":-3.003747,"median":17.87218,"eighty":27.96152,"marketCap":2298552627},{"date":"2025-11-14","current":-2.872173,"twenty":-2.952467,"median":17.87218,"eighty":27.96152,"marketCap":2426986369},{"date":"2025-11-21","current":-2.606744,"twenty":-2.890145,"median":17.87218,"eighty":27.96152,"marketCap":2202698684},{"date":"2025-11-28","current":-2.862116,"twenty":-2.871421,"median":17.87218,"eighty":27.96152,"marketCap":2418488177},{"date":"2025-12-05","current":-3.153738,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2664908806},{"date":"2025-12-12","current":-3.279801,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2771432010},{"date":"2025-12-19","current":-3.20676,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2709712557},{"date":"2025-12-26","current":-3.213253,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2715198731},{"date":"2026-01-02","current":-3.177352,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2684862348},{"date":"2026-01-09","current":-3.244506,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2741607351},{"date":"2026-01-16","current":-3.475212,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2936553892},{"date":"2026-01-23","current":-3.416723,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2887130825},{"date":"2026-01-30","current":-3.34307,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2824894371},{"date":"2026-02-06","current":-4.1748,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2888961309},{"date":"2026-02-13","current":-4.035926,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2792860901},{"date":"2026-02-20","current":-4.180751,"twenty":-2.870292,"median":17.87218,"eighty":27.96152,"marketCap":2893079898}],"updateTime":1771845422429},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ASH\",pageSize:20,pageCount:7,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1115731169","title":"HUTCHMED (00013) to Present Clinical Data at 2025 ESMO Asia Congress and ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=1115731169","media":"Stock News","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1115731169?lang=en_us&edition=fundamental","pubTime":"2025-11-27 08:08","pubTimestamp":1764202097,"startTime":"0","endTime":"0","summary":"HUTCHMED (00013) announced that updated and latest data from several studies of its self-developed compounds will be presented at two major medical conferences in December 2025. The European Society...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASH","BK4007","LU2463526074.USD","00013","BK1191","BK4109","BK1588","BK4585","BK4588","BK1587","BK4531","HCM"],"gpt_icon":0},{"id":"2586299606","title":"HUTCHMED Highlights Clinical Data to be Presented at the 2025 ESMO Asia Congress and the 2025 ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2586299606","media":"GlobeNewswire","labels":["conferences"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586299606?lang=en_us&edition=fundamental","pubTime":"2025-11-27 08:00","pubTimestamp":1764201600,"startTime":"0","endTime":"0","summary":"HONG KONG and SHANGHAI and FLORHAM PARK, N.J., Nov.  27, 2025  (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED”) (Nasdaq/AIM:HCM; HKEX:13) today announces that new and updated data from severa","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/27/3195434/0/en/HUTCHMED-Highlights-Clinical-Data-to-be-Presented-at-the-2025-ESMO-Asia-Congress-and-the-2025-ASH-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","LU0130102774.USD","LU1244550494.USD","ASH","RCC","LU0130517989.USD","LU0128525689.USD","BK1587","LU1201861249.SGD","BK4561","LU0072461881.USD","BK1191","BK4588","LU0320765646.SGD","LU0648001328.SGD","BK4555","BK4516","LU2286300806.USD","BK4539","BK4097","LU0980610538.SGD","LU0310800965.SGD","BK4574","AG","LU0162691827.USD","LU1267930227.SGD","PD","00013","BK4099","LU2456880835.USD","BK4560","BK4504","BK4585","BK4559","LU2125154935.USD","LU2236285917.USD","F","LU1244550577.SGD","BK4207","LU0170899867.USD","IE00BSNM7G36.USD","LU2360032135.SGD","LU2462157665.USD","S","BK1588","BK4534","LU0106831901.USD","LU0477156953.USD","LU1244550221.USD","BK4109"],"gpt_icon":0},{"id":"2586441294","title":"Novartis data underscore pioneering scientific innovation in Hematology and Oncology at ASH and SABCS","url":"https://stock-news.laohu8.com/highlight/detail?id=2586441294","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586441294?lang=en_us&edition=fundamental","pubTime":"2025-11-25 14:15","pubTimestamp":1764051300,"startTime":"0","endTime":"0","summary":"Positive results from ianalumab pivotal Phase III trial in ITP patients previously treated with corticosteroids to be presented as late-breakerScemblix data across clinical and real-world settings off","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/25/3194022/0/en/Novartis-data-underscore-pioneering-scientific-innovation-in-Hematology-and-Oncology-at-ASH-and-SABCS.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBC","OS","IS","ASH","PFS","BK4109","BK4588","BK4195","ET","BK4190","BK4211","ITP","BK4590","BC","ASC","BK4585","DDFS","BK4144","LU2463526074.USD","FUL","BK4199","BK4561","BK4581","BK4097"],"gpt_icon":0},{"id":"2586918334","title":"Eli Lilly to present data from 2 Jaypirca studies at ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2586918334","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586918334?lang=en_us&edition=fundamental","pubTime":"2025-11-25 01:05","pubTimestamp":1764003947,"startTime":"0","endTime":"0","summary":"Eli Lilly (LLY) announced that data from studies of Jaypirca, the first and only approved non-covalent Bruton tyrosine kinase inhibitor, will be pr...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/eli-lilly-to-present-data-from-2-jaypirca-studies-at-ash-annual-meeting-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/eli-lilly-to-present-data-from-2-jaypirca-studies-at-ash-annual-meeting-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1064131342.USD","LU0640476718.USD","LU0323591593.USD","SG9999015945.SGD","SG9999015986.USD","SG9999018865.SGD","LU0823416689.USD","LU1983299246.USD","SG9999017495.SGD","LU1989771016.USD","LU2491049909.HKD","IE0004445239.USD","LU2324357040.USD","LU2264538146.SGD","BK4534","LU1093756325.SGD","LU2361044865.SGD","LU2750360997.AUD","LU2471134879.HKD","LU2471134952.CNY","LU0471298694.HKD","LU0256863902.USD","LU0820561909.HKD","LU2357305700.SGD","LU1023059063.AUD","SGXZ31699556.SGD","LLY","LU2361044949.HKD","LU0417517546.SGD","LU1917777945.USD","LU2168564222.USD","LU0320765059.SGD","LU0096364046.USD","LU0689472784.USD","LU0198837287.USD","LU2463526074.USD","LU1280957306.USD","LU1035775433.USD","LU2602419157.SGD","LU2471134523.USD","LU1988902786.USD","LU2106854487.HKD","LU0823434740.USD","LU0943347566.SGD","IE00B4R5TH58.HKD","LU1804176565.USD","ASH","SG9999014906.USD","LU0354030438.USD","IE00BKPKM429.USD"],"gpt_icon":0},{"id":"2585372464","title":"Adaptive Biotechnologies Announces Nearly 90 Abstracts Featuring clonoSEQ® MRD Testing Across a Range of Blood Cancers to be Presented at the 67th ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2585372464","media":"GlobeNewswire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585372464?lang=en_us&edition=fundamental","pubTime":"2025-11-24 20:30","pubTimestamp":1763987400,"startTime":"0","endTime":"0","summary":"Record-setting presence at ASH reflects widespread recognition of clonoSEQ as a standard-of-care tool for personalizing patient care and accelerating drug developmentSEATTLE, Nov.  24, 2025  (GLOBE NE","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/24/3193393/0/en/Adaptive-Biotechnologies-Announces-Nearly-90-Abstracts-Featuring-clonoSEQ-MRD-Testing-Across-a-Range-of-Blood-Cancers-to-be-Presented-at-the-67th-ASH-Annual-Meeting.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1571399168.USD","BK4109","ALL","BK4533","LU2463526074.USD","LU0985320562.USD","ASH","NGS","BK4585","BK4588","BK4179","LU1699723380.USD","BK4107","LU2355687059.USD"],"gpt_icon":0},{"id":"2585658461","title":"Press Release: BioLineRx Reports Third Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2585658461","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2585658461?lang=en_us&edition=fundamental","pubTime":"2025-11-24 20:00","pubTimestamp":1763985600,"startTime":"0","endTime":"0","summary":"- Establishes joint venture with Hemispherian AS to advance GLIX1, a first-in-class, oral, small molecule targeting DNA damage response in glioblastoma and other cancers -. - Phase 1/2a clinical trial of GLIX1 expected to commence in Q1 2026 -. - Management to host conference call today, November 24 , at 8:30 am EST -. TEL AVIV, Israel, Nov. 24, 2025 /PRNewswire/ -- BioLineRx Ltd.  , a development stage biopharmaceutical company pursuing life-changing therapies in oncology and rare diseases, today reported its unaudited financial results for the quarter ended September 30, 2025, and provided a corporate update.\"At the same time, the ongoing CheMo4METPANC Phase 2b clinical trial of motixafortide in metastatic pancreatic cancer, which is being led by Columbia University and supported by both Regeneron and BioLineRx, continues to progress, giving us a second opportunity to leverage our drug development expertise to bring true innovation to patients with difficult-to-treat cancers,\" Mr. Se","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PFS","BK4121","LU2463526074.USD","LU2413666699.HKD","BK4211","BK4567","IE00BLDYK493.USD","IE00BFXG0V08.USD","LU1721428933.USD","BK4195","BK4533","MTD","IE00BYQQ9H92.USD","ASH","BK4109","LU1093756168.USD","BLRX","BK4588","LU0347712357.USD","IE00B64QTZ34.USD","BK4139","SCD","LU2211817866.USD","BK4585","PB","LU2413666426.HKD","BK4548","LU1093756325.SGD"],"gpt_icon":0},{"id":"2584153997","title":"PeproMene Bio's PMB-CT01 BAFFR-CAR T Data Selected for Two Oral Presentations at 67th ASH 2025 Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2584153997","media":"prnewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584153997?lang=en_us&edition=fundamental","pubTime":"2025-11-20 23:12","pubTimestamp":1763651520,"startTime":"0","endTime":"0","summary":"IRVINE, Calif., Nov. 20, 2025 /PRNewswire/ -- PeproMene Bio, Inc., a clinical-stage biotechnology company developing novel therapies for relapsed and refractory (r/r) B-cell malignancies, announced that two abstracts from its ongoing Phase 1 studies of PMB-CT01  have been accepted for oral presentations at the 2025 American Society of Hematology  Annual Meeting.The abstracts showcase the emerging safety and efficacy profile of PMB-CT01 in heavily pretreated r/r B-cell Acute Lymphoblastic Leukemia  and r/r B-cell Non-Hodgkin Lymphoma , including patients who failed prior CD19-directed therapy or presented with CD19-negative disease. Interim results from the Phase 1 dose-escalation studies  support BAFF-R as a differentiated target designed to overcome CD19 antigen escape while maintaining durable activity and low toxicity.Safety: PMB-CT01 demonstrated an exceptionally favorable tolerability profile. No Grade 1 Cytokine Release Syndrome  and no Grade 1 Immune Effector Cell-Associated Neu","market":"us","thumbnail":"https://mma.prnewswire.com/media/1972356/Pepromene_Bio_Inc__Logo.jpg?w=300","type":0,"news_type":0,"thumbnails":["https://mma.prnewswire.com/media/1972356/Pepromene_Bio_Inc__Logo.jpg?w=300"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.prnewswire.com/apac/news-releases/pepromene-bios-pmb-ct01-baffr-car-t-data-selected-for-two-oral-presentations-at-67th-ash-2025-annual-meeting-302621280.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4230","BK4161","LU2065731478.USD","BK7057","CRS","ASH","IE0031619046.USD","ASH.AU","CAR","BK4109","CR","LU2463526074.USD","BK7095","BK7501","IE00B19Z4B17.USD","BK4187","BK4022","HCT.AU","IE00B66KJ199.SGD","BK4006","CRS.AU","LU0963586101.USD","IE00B7SZL793.SGD","BK7111"],"gpt_icon":0},{"id":"2584137397","title":"Minovia’s mitochondrial augmentation tech to be featured at ASH meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2584137397","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584137397?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:50","pubTimestamp":1763646637,"startTime":"0","endTime":"0","summary":"Minovia Therapeutics announces that data collected by research teams at Memorial Sloan Kettering Cancer Center and Shaare Zedek Medical Center feat...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/minovias-mitochondrial-augmentation-tech-to-be-featured-at-ash-meeting-thefly?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/minovias-mitochondrial-augmentation-tech-to-be-featured-at-ash-meeting-thefly?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2463526074.USD","BK4109","ASH"],"gpt_icon":0},{"id":"2584132177","title":"Minovia Therapeutics Mitochondrial Augmentation Technology to be Featured in Presentation and Workshop at the 67th ASH Annual Meeting and Exposition","url":"https://stock-news.laohu8.com/highlight/detail?id=2584132177","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584132177?lang=en_us&edition=fundamental","pubTime":"2025-11-20 21:30","pubTimestamp":1763645400,"startTime":"0","endTime":"0","summary":"Results from pre-clinical studies conducted by scientists at Memorial Sloan Kettering Cancer Center show delayed leukemic progression and improved survival; Results from Phase 1 clinical trial in Shaa","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/20/3191907/0/en/Minovia-Therapeutics-Mitochondrial-Augmentation-Technology-to-be-Featured-in-Presentation-and-Workshop-at-the-67th-ASH-Annual-Meeting-and-Exposition.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MAT","ASH","LENZ","BK4539","BK4109","BK4190","BK4007","BK4139","LU2463526074.USD"],"gpt_icon":0},{"id":"2584715639","title":"Ashland Maintains Quarterly Dividend at $0.415 a Share, Payable Dec. 15 to Shareholders of Record on Dec. 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2584715639","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584715639?lang=en_us&edition=fundamental","pubTime":"2025-11-20 06:38","pubTimestamp":1763591913,"startTime":"0","endTime":"0","summary":"Ashland Maintains Quarterly Dividend at $0.415 a Share, Payable Dec. 15 to Shareholders of Record on Dec. 1","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4109","LU2463526074.USD","ASH"],"gpt_icon":0},{"id":"2584517979","title":"Ashland Inc. announces $0.415 quarterly dividend","url":"https://stock-news.laohu8.com/highlight/detail?id=2584517979","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584517979?lang=en_us&edition=fundamental","pubTime":"2025-11-20 06:01","pubTimestamp":1763589671,"startTime":"0","endTime":"0","summary":"Ashland Inc. has announced a quarterly cash dividend of $0.415 per share on its common stock. This is the value of the dividend declared by the company's board of directors.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ashland Inc. published the original content used to generate this news brief via GlobeNewswire  on November 19, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251119:nNDL9SBmck:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4112","BK4109","LU2095319765.USD","LU2463526074.USD","IE00B64PRP62.GBP","ASH","LU0314104364.USD","LU2210150020.SGD","IE00BKPKM429.USD","NDAQ","IE00B3QW5Z07.USD","IE00BGHQF748.EUR","LU2210149790.SGD","BK4588","BK4585"],"gpt_icon":0},{"id":"2583637798","title":"A Fresh Look at Terns Pharmaceuticals (TERN) Valuation Following New CARDINAL Trial Results and ASH Presentation","url":"https://stock-news.laohu8.com/highlight/detail?id=2583637798","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583637798?lang=en_us&edition=fundamental","pubTime":"2025-11-15 14:26","pubTimestamp":1763188018,"startTime":"0","endTime":"0","summary":"Terns Pharmaceuticals (TERN) is turning heads after sharing new results from its CARDINAL trial on TERN-701, a treatment aimed at chronic myeloid leukemia. The data was selected for oral presentation at the upcoming ASH Annual Meeting and has sparked fresh interest in the company’s pipeline.\nSee our latest analysis for Terns Pharmaceuticals.\nWith momentum building around positive data from the CARDINAL trial and a spotlight on Terns at both the ASH conference and major investor events, the...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tern/terns-pharmaceuticals/news/a-fresh-look-at-terns-pharmaceuticals-tern-valuation-followi","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-tern/terns-pharmaceuticals/news/a-fresh-look-at-terns-pharmaceuticals-tern-valuation-followi","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4109","BK4007","LU2463526074.USD","TERN","ASH"],"gpt_icon":0},{"id":"2583684387","title":"Ashland (ASH) Issues 2026 Growth Outlook After Mixed FY25 Results – Is Margin Improvement Sustainable?","url":"https://stock-news.laohu8.com/highlight/detail?id=2583684387","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583684387?lang=en_us&edition=fundamental","pubTime":"2025-11-15 03:26","pubTimestamp":1763148376,"startTime":"0","endTime":"0","summary":"Ashland Inc. recently reported fourth-quarter and full-year earnings for the period ended September 30, 2025, revealing quarterly sales of US$478 million and net income of US$32 million, along with full-year sales of US$1.82 billion and a net loss of US$845 million.\nDespite a decline in annual sales, the company achieved higher quarterly net income and issued guidance for fiscal 2026 projecting up to 5% organic sales growth compared to the prior year.\nNext, we’ll explore how Ashland’s...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/2024000-choice2-main-header/1585186739035","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/2024000-choice2-main-header/1585186739035"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/materials/nyse-ash/ashland/news/ashland-ash-issues-2026-growth-outlook-after-mixed-fy25-resu","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/materials/nyse-ash/ashland/news/ashland-ash-issues-2026-growth-outlook-after-mixed-fy25-resu","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["ASH","ASH.AU","BK4109","BK7057","LU2463526074.USD"],"gpt_icon":0},{"id":"2583503836","title":"Press Release: TuHURA Biosciences, Inc. Reports Third Quarter 2025 Financial Results and Provides a Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583503836","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583503836?lang=en_us&edition=fundamental","pubTime":"2025-11-14 20:00","pubTimestamp":1763121600,"startTime":"0","endTime":"0","summary":"Phase 3 accelerated approval trial of IFx-2.0 as adjunctive therapy with Keytruda  as a first-line therapy for advanced and metastatic Merkel cell carcinoma  is underway, conducted under Special Protocol Assessment  agreement with the U.S. Food and Drug Administration . Company's Delta Opioid Receptor  technology selected for an oral presentation, along with 2 poster presentations at the 67 Annual American Society of Hematology  Annual Meeting and Exposition, taking place in Orlando, Florida on December 6-9, 2025. TAMPA, Fla., Nov. 14, 2025 /PRNewswire/ -- TuHURA Biosciences, Inc.  , a Phase 3 immuno-oncology company developing novel therapeutics to overcome resistance to cancer immunotherapy, today reported financial results for the Company's third quarter ended September 30, 2025, and provided a corporate update.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2361045086.USD","ASH","BK4022","IE00BJT1NW94.SGD","LU1989771016.USD","LU0203347892.USD","SG9999014575.USD","SGXZ57979304.SGD","LU0122379950.USD","SG9999002232.USD","IE00BLSP4452.SGD","LU1941712264.USD","LU1057294990.SGD","LU1941712348.USD","LU2468319806.SGD","LU1571399168.USD","MRK","SG9999015341.SGD","LU0106261372.USD","LU2461242641.AUD","LU1116320737.USD","HURA","SG9999001176.USD","SG9999001440.SGD","BK4007","LU1066051498.USD","LU1929549753.HKD","LU0266013472.USD","BK4585","LU0965509101.SGD","BK4559","LU1699723380.USD","R","LU0058720904.USD","LU1066051225.USD","BK4232","BK4139","IE00BBT3K403.USD","LU0098860793.USD","LU1069347547.HKD","LU2106854487.HKD","IE00BLSP4239.USD","LU1093756325.SGD","BK4550","IE00BFTCPJ56.SGD","LU0320765489.SGD","SG9999015358.SGD","IE00BSNM7G36.USD","LU2361044949.HKD","LU1291159041.SGD"],"gpt_icon":0},{"id":"2583512745","title":"Press Release: Senti Bio Reports Third Quarter 2025 Financial Results and Confirms Next Clinical Data Readout for Phase 1 SENTI-202 Study in Acute Myeloid Leukemia (AML) at the American Society of Hematology Annual Meeting in December","url":"https://stock-news.laohu8.com/highlight/detail?id=2583512745","media":"Dow Jones","labels":["conferences","dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583512745?lang=en_us&edition=fundamental","pubTime":"2025-11-14 05:30","pubTimestamp":1763069400,"startTime":"0","endTime":"0","summary":"SOUTH SAN FRANCISCO, Calif., Nov. 13, 2025  -- Senti Biosciences, Inc.  , a clinical-stage biotechnology company developing next-generation cell and gene therapies using its proprietary Gene Circuit platform, today reported financial results for the third quarter of 2025 and provided a summary of recent pipeline and corporate highlights.DRIVING TOWARDS NEXT DATA MILESTONE FOR PHASE 1 SENTI-202 STUDY IN AML. -- Recently announced that abstracts detailing certain clinical and. correlative results for SENTI-202 were accepted for oral and poster. presentations, respectively, at the upcoming American Society of. Hematology  Annual Meeting to be held December 6-9, 2025 in Orlando. Florida. At the conference, the Company plans to present updated clinical. data from the patients included in the published abstracts, as well as. additional patients' clinical data from a more recent data-cut. Senti. will also host a live webcast during the meeting to discuss the results.-- Details for the Company","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"conferences,dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4117","BK4109","AFG","LU2463526074.USD","SNTI","BK4107","ASH","BK4539","BK4139"],"gpt_icon":0},{"id":"2583966185","title":"Fate Therapeutics Reports Third Quarter 2025 Financial Results and Business Updates","url":"https://stock-news.laohu8.com/highlight/detail?id=2583966185","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583966185?lang=en_us&edition=fundamental","pubTime":"2025-11-13 21:30","pubTimestamp":1763040600,"startTime":"0","endTime":"0","summary":"Authorization Received from UK and EU Authorities to Activate ex-US Clinical Trial Sites Supporting the Ongoing Patient Enrollment of FT819, an Off-the-Shelf CD19-targeted CAR T-cell Product Candidate","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/13/3187342/24675/en/Fate-Therapeutics-Reports-Third-Quarter-2025-Financial-Results-and-Business-Updates.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CAR","BK4109","UK","BK4233","IE00B66KJ199.SGD","BK4205","SLE","IIM","LU2463526074.USD","BK4213","BK4230","BK4187","BK4528","BK4077","EMA","IE00B19Z4B17.USD","BK4156","IE0031619046.USD","LU0456854461.SGD","FATE","LU2065731478.USD","ACR","CRC","BK4022","LU0266512127.USD","ASH","BK4006","BK4139","IE00B7SZL793.SGD","BK4081","LU0963586101.USD","BK4110","CRS"],"gpt_icon":0},{"id":"2583056276","title":"Regeneron Highlights Progress at American Society of Hematology (ASH), with Updated Data in Multiple Myeloma, Lymphoma and Paroxysmal Nocturnal Hemoglobinuria Programs","url":"https://stock-news.laohu8.com/highlight/detail?id=2583056276","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583056276?lang=en_us&edition=fundamental","pubTime":"2025-11-13 20:00","pubTimestamp":1763035200,"startTime":"0","endTime":"0","summary":"Oral presentation of Lynozyfic (linvoseltamab-gcpt) data in newly diagnosed multiple myeloma from LINKER-MM4, the first trial to evaluate a BCMAxCD3 bispecific antibody as a monotherapy in this settin","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/11/13/3187146/0/en/Regeneron-Highlights-Progress-at-American-Society-of-Hematology-ASH-with-Updated-Data-in-Multiple-Myeloma-Lymphoma-and-Paroxysmal-Nocturnal-Hemoglobinuria-Programs.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU2065732104.USD","PRGS","ET","LU0889565916.HKD","BK4006","LU2362541513.USD","LU0823434583.USD","LU0320765992.SGD","BK4590","LU1974910355.USD","IRR","BK4187","LU0109394709.USD","LU1917777945.USD","IE00B66KJ199.SGD","IE00B19Z4B17.USD","LU2362540622.SGD","LU2089984988.USD","IE00B7SZL793.SGD","LU0823434740.USD","LU0289739699.SGD","BK4107","BK4117","BK4144","IE0031619046.USD","ASH","BK4581","LU2065731478.USD","LU0053666078.USD","LU2463526074.USD","LU2106854487.HKD","LU2237438978.USD","LU2362541273.HKD","BK4585","BK4139","BK4109","LU0058720904.USD","LU0963586101.USD","LU2023250504.SGD","LU2468319806.SGD","AFG","BK4561","BK4097","LU0114720955.EUR","REGN","LU0823416689.USD","LU0882574055.USD","BK4588","CRS"],"gpt_icon":0},{"id":"2583568100","title":"Ascentage Pharma (SEHK:6855): Evaluating Valuation After ASH Meeting Spotlights Pipeline Progress","url":"https://stock-news.laohu8.com/highlight/detail?id=2583568100","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583568100?lang=en_us&edition=fundamental","pubTime":"2025-11-13 15:38","pubTimestamp":1763019485,"startTime":"0","endTime":"0","summary":"Ascentage Pharma Group International (SEHK:6855) saw attention rise after announcing that new clinical and preclinical results on olverembatinib, lisaftoclax, and APG-5918 will be featured at the 67th ASH Annual Meeting. This recognition for its drug candidates highlights the company’s development programs and keeps them in focus for investors.\nSee our latest analysis for Ascentage Pharma Group International.\nThis spotlight at ASH comes after a year of strong momentum for Ascentage Pharma...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice1-main-header/1585186710114"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6855/ascentage-pharma-group-international-shares/news/ascentage-pharma-sehk6855-evaluating-valuation-after-ash-mee","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/hk/pharmaceuticals-biotech/hkg-6855/ascentage-pharma-group-international-shares/news/ascentage-pharma-sehk6855-evaluating-valuation-after-ash-mee","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["PRGS","ASH","06855","LU2065732104.USD","LU2463526074.USD","BK4109","BK1574","BK1161","BK4097"],"gpt_icon":0},{"id":"2583958899","title":"Press Release: SELLAS Life Sciences Reports Third Quarter 2025 Financial Results and Provides Corporate Update","url":"https://stock-news.laohu8.com/highlight/detail?id=2583958899","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2583958899?lang=en_us&edition=fundamental","pubTime":"2025-11-13 05:05","pubTimestamp":1762981500,"startTime":"0","endTime":"0","summary":"-- Hosted Virtual R&D Day Highlighting GPS and SLS009 Programs in AML --. -- Positive Phase 2 Data for SLS009 in R/R AML Accepted for Presentation at ASH 2025; Initiation of Trial Including Newly Diagnosed First-Line AML Patients Expected in Q1 2026 --. -- $44.3 Million in Cash and Cash Equivalents as of September 30, 2025; Additional $29.1 Million in Proceeds Received in October 2025 through Warrant Exercises --. Dr. Stergiou continued, \"Our recent R&D Day was a resounding success and provided an excellent opportunity to share program updates and hear directly from leading experts who expressed genuine enthusiasm for both GPS and SLS009. These achievements highlight the breadth and promise of our pipeline and underscore the complementary potential of our two programs to meaningfully improve outcomes for patients with AML and other hematologic cancers. With a strong financial foundation following the recent warrant exercises and multiple catalysts ahead, we believe SELLAS is entering a","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ASH","BK4139","BK4109","LU2463526074.USD","SLS"],"gpt_icon":0},{"id":"2582734423","title":"Ashland  : Deutsche Bank Raises Target Price to $58 From $55","url":"https://stock-news.laohu8.com/highlight/detail?id=2582734423","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582734423?lang=en_us&edition=fundamental","pubTime":"2025-11-12 20:01","pubTimestamp":1762948897,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251112:nAQN2L7KNL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4109","ASH","LU2463526074.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":7,"totalSize":198,"code":"91000000","status":"200"}]}}